Magnetic resonance spectroscopy imaging-directed transrectal ultrasound biopsy increases prostate cancer detection in men with prostate-specific antigen between 4-10 ng/mL and normal digital rectal examination

Objectives To evaluate the ability of magnetic resonance spectroscopic imaging to improve prostate cancer detection rate. Methods A retrospective analysis was carried out of 278 men with prostate‐specific antigen in the range of 4–10 ng/mL and normal digital rectal examination who underwent transrec...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of urology 2014-03, Vol.21 (3), p.257-262
Hauptverfasser: Javali, Tarun Dilip, Dwivedi, Durgesh Kumar, Kumar, Rajeev, Jagannathan, Naranamangalam Raghunathan, Thulkar, Sanjay, Dinda, Amit Kumar
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 262
container_issue 3
container_start_page 257
container_title International journal of urology
container_volume 21
creator Javali, Tarun Dilip
Dwivedi, Durgesh Kumar
Kumar, Rajeev
Jagannathan, Naranamangalam Raghunathan
Thulkar, Sanjay
Dinda, Amit Kumar
description Objectives To evaluate the ability of magnetic resonance spectroscopic imaging to improve prostate cancer detection rate. Methods A retrospective analysis was carried out of 278 men with prostate‐specific antigen in the range of 4–10 ng/mL and normal digital rectal examination who underwent transrectal ultrasound‐guided prostate biopsy. Outcomes were compared between men who had a standard biopsy versus those who also underwent a prebiopsy magnetic resonance spectroscopic imaging. Men with an abnormal voxel on magnetic resonance spectroscopic imaging had standard transrectal ultrasound biopsies plus biopsies directed to the abnormal voxels. Results The study group (n = 140) and control group (n = 138) were similar in baseline parameters, such as mean age, prostate size and mean prostate‐specific antigen. The overall cancer detection in the magnetic resonance spectroscopic imaging positive group (24.4%) was more than double that of the control group (10.1%). On comparing the magnetic resonance spectroscopic imaging results with the transrectal ultrasound biopsy findings, magnetic resonance spectroscopic imaging had 95.6% sensitivity, 41.9% specificity, a positive predictive value of 24.4%, a negative predictive value of 98% and an accuracy of 51.4%. Conclusions Magnetic resonance spectroscopic imaging‐directed transrectal ultrasound biopsy increases the cancer detection rate compared with standard transrectal ultrasound biopsy in patients with normal digital rectal examination and elevated prostate‐specific antigen in the range of 4–10 ng/mL.
doi_str_mv 10.1111/iju.12258
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1504162485</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1504162485</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3178-8b1d7955ddbab36b566b3e5c26db18193197e3937c09f31a8d9d9b6aa64388fe3</originalsourceid><addsrcrecordid>eNp1kc1u1DAQxyMEokvhwAsgH-GQbhznwz7CAm3R8iFBBTfLsWeDS-IE29F2b73yfLwBT8KE3e4NX8b2_OY_X0nylGZnFM_SXk9nNM9Lfi9Z0KLI0zwr8vvJIhNUpJzW-UnyKITrLKMsp_xhcpIzwbO6EIvk93vVOohWEw9hcMppIGEEHf0Q9DDuiO1Va12bGuvxFwyJXrkw31VHpg5fYZicIY0dxoC40x5UgEBGVIgqAtGzqCcGIgbZwSFDenBka-P3I5XOSe0G61Au2hbdDcQtoC1Smv25_eXaZb9GpyFu8D3mNra1cw2HUuBG9dapOcHj5MFGdQGeHOxpcvX2zZfVRbr-eH65erlONaM1T3lDTS3K0phGNaxqyqpqGJQ6r0xDORWMihqYYLXOxIZRxY0woqmUqgrG-QbYafJ8r4tN_JwgRNnboKHrlINhCpKWWUGrvOAloi_2qMZ-cXobOXqcrN9Jmsl5hxJ3KP_tENlnB9mp6cEcybulIbDcA1vbwe7_SvLy3dWdZLqPsCHCzTFC-R-yqlldyq8fzuXq9advr0T1GRP9BQq3vFQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1504162485</pqid></control><display><type>article</type><title>Magnetic resonance spectroscopy imaging-directed transrectal ultrasound biopsy increases prostate cancer detection in men with prostate-specific antigen between 4-10 ng/mL and normal digital rectal examination</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Javali, Tarun Dilip ; Dwivedi, Durgesh Kumar ; Kumar, Rajeev ; Jagannathan, Naranamangalam Raghunathan ; Thulkar, Sanjay ; Dinda, Amit Kumar</creator><creatorcontrib>Javali, Tarun Dilip ; Dwivedi, Durgesh Kumar ; Kumar, Rajeev ; Jagannathan, Naranamangalam Raghunathan ; Thulkar, Sanjay ; Dinda, Amit Kumar</creatorcontrib><description>Objectives To evaluate the ability of magnetic resonance spectroscopic imaging to improve prostate cancer detection rate. Methods A retrospective analysis was carried out of 278 men with prostate‐specific antigen in the range of 4–10 ng/mL and normal digital rectal examination who underwent transrectal ultrasound‐guided prostate biopsy. Outcomes were compared between men who had a standard biopsy versus those who also underwent a prebiopsy magnetic resonance spectroscopic imaging. Men with an abnormal voxel on magnetic resonance spectroscopic imaging had standard transrectal ultrasound biopsies plus biopsies directed to the abnormal voxels. Results The study group (n = 140) and control group (n = 138) were similar in baseline parameters, such as mean age, prostate size and mean prostate‐specific antigen. The overall cancer detection in the magnetic resonance spectroscopic imaging positive group (24.4%) was more than double that of the control group (10.1%). On comparing the magnetic resonance spectroscopic imaging results with the transrectal ultrasound biopsy findings, magnetic resonance spectroscopic imaging had 95.6% sensitivity, 41.9% specificity, a positive predictive value of 24.4%, a negative predictive value of 98% and an accuracy of 51.4%. Conclusions Magnetic resonance spectroscopic imaging‐directed transrectal ultrasound biopsy increases the cancer detection rate compared with standard transrectal ultrasound biopsy in patients with normal digital rectal examination and elevated prostate‐specific antigen in the range of 4–10 ng/mL.</description><identifier>ISSN: 0919-8172</identifier><identifier>EISSN: 1442-2042</identifier><identifier>DOI: 10.1111/iju.12258</identifier><identifier>PMID: 23980749</identifier><language>eng</language><publisher>Australia: Blackwell Publishing Ltd</publisher><subject>Digital Rectal Examination ; Endoscopic Ultrasound-Guided Fine Needle Aspiration - methods ; Humans ; magnetic resonance spectroscopic imaging ; Magnetic Resonance Spectroscopy ; Male ; Middle Aged ; prostate cancer ; Prostate-Specific Antigen - blood ; Prostatic Neoplasms - blood ; Prostatic Neoplasms - pathology ; Retrospective Studies ; transrectal ultrasound-guided biopsy</subject><ispartof>International journal of urology, 2014-03, Vol.21 (3), p.257-262</ispartof><rights>2013 The Japanese Urological Association</rights><rights>2013 The Japanese Urological Association.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3178-8b1d7955ddbab36b566b3e5c26db18193197e3937c09f31a8d9d9b6aa64388fe3</citedby><cites>FETCH-LOGICAL-c3178-8b1d7955ddbab36b566b3e5c26db18193197e3937c09f31a8d9d9b6aa64388fe3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fiju.12258$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fiju.12258$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23980749$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Javali, Tarun Dilip</creatorcontrib><creatorcontrib>Dwivedi, Durgesh Kumar</creatorcontrib><creatorcontrib>Kumar, Rajeev</creatorcontrib><creatorcontrib>Jagannathan, Naranamangalam Raghunathan</creatorcontrib><creatorcontrib>Thulkar, Sanjay</creatorcontrib><creatorcontrib>Dinda, Amit Kumar</creatorcontrib><title>Magnetic resonance spectroscopy imaging-directed transrectal ultrasound biopsy increases prostate cancer detection in men with prostate-specific antigen between 4-10 ng/mL and normal digital rectal examination</title><title>International journal of urology</title><addtitle>Int J Urol</addtitle><description>Objectives To evaluate the ability of magnetic resonance spectroscopic imaging to improve prostate cancer detection rate. Methods A retrospective analysis was carried out of 278 men with prostate‐specific antigen in the range of 4–10 ng/mL and normal digital rectal examination who underwent transrectal ultrasound‐guided prostate biopsy. Outcomes were compared between men who had a standard biopsy versus those who also underwent a prebiopsy magnetic resonance spectroscopic imaging. Men with an abnormal voxel on magnetic resonance spectroscopic imaging had standard transrectal ultrasound biopsies plus biopsies directed to the abnormal voxels. Results The study group (n = 140) and control group (n = 138) were similar in baseline parameters, such as mean age, prostate size and mean prostate‐specific antigen. The overall cancer detection in the magnetic resonance spectroscopic imaging positive group (24.4%) was more than double that of the control group (10.1%). On comparing the magnetic resonance spectroscopic imaging results with the transrectal ultrasound biopsy findings, magnetic resonance spectroscopic imaging had 95.6% sensitivity, 41.9% specificity, a positive predictive value of 24.4%, a negative predictive value of 98% and an accuracy of 51.4%. Conclusions Magnetic resonance spectroscopic imaging‐directed transrectal ultrasound biopsy increases the cancer detection rate compared with standard transrectal ultrasound biopsy in patients with normal digital rectal examination and elevated prostate‐specific antigen in the range of 4–10 ng/mL.</description><subject>Digital Rectal Examination</subject><subject>Endoscopic Ultrasound-Guided Fine Needle Aspiration - methods</subject><subject>Humans</subject><subject>magnetic resonance spectroscopic imaging</subject><subject>Magnetic Resonance Spectroscopy</subject><subject>Male</subject><subject>Middle Aged</subject><subject>prostate cancer</subject><subject>Prostate-Specific Antigen - blood</subject><subject>Prostatic Neoplasms - blood</subject><subject>Prostatic Neoplasms - pathology</subject><subject>Retrospective Studies</subject><subject>transrectal ultrasound-guided biopsy</subject><issn>0919-8172</issn><issn>1442-2042</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kc1u1DAQxyMEokvhwAsgH-GQbhznwz7CAm3R8iFBBTfLsWeDS-IE29F2b73yfLwBT8KE3e4NX8b2_OY_X0nylGZnFM_SXk9nNM9Lfi9Z0KLI0zwr8vvJIhNUpJzW-UnyKITrLKMsp_xhcpIzwbO6EIvk93vVOohWEw9hcMppIGEEHf0Q9DDuiO1Va12bGuvxFwyJXrkw31VHpg5fYZicIY0dxoC40x5UgEBGVIgqAtGzqCcGIgbZwSFDenBka-P3I5XOSe0G61Au2hbdDcQtoC1Smv25_eXaZb9GpyFu8D3mNra1cw2HUuBG9dapOcHj5MFGdQGeHOxpcvX2zZfVRbr-eH65erlONaM1T3lDTS3K0phGNaxqyqpqGJQ6r0xDORWMihqYYLXOxIZRxY0woqmUqgrG-QbYafJ8r4tN_JwgRNnboKHrlINhCpKWWUGrvOAloi_2qMZ-cXobOXqcrN9Jmsl5hxJ3KP_tENlnB9mp6cEcybulIbDcA1vbwe7_SvLy3dWdZLqPsCHCzTFC-R-yqlldyq8fzuXq9advr0T1GRP9BQq3vFQ</recordid><startdate>201403</startdate><enddate>201403</enddate><creator>Javali, Tarun Dilip</creator><creator>Dwivedi, Durgesh Kumar</creator><creator>Kumar, Rajeev</creator><creator>Jagannathan, Naranamangalam Raghunathan</creator><creator>Thulkar, Sanjay</creator><creator>Dinda, Amit Kumar</creator><general>Blackwell Publishing Ltd</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201403</creationdate><title>Magnetic resonance spectroscopy imaging-directed transrectal ultrasound biopsy increases prostate cancer detection in men with prostate-specific antigen between 4-10 ng/mL and normal digital rectal examination</title><author>Javali, Tarun Dilip ; Dwivedi, Durgesh Kumar ; Kumar, Rajeev ; Jagannathan, Naranamangalam Raghunathan ; Thulkar, Sanjay ; Dinda, Amit Kumar</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3178-8b1d7955ddbab36b566b3e5c26db18193197e3937c09f31a8d9d9b6aa64388fe3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Digital Rectal Examination</topic><topic>Endoscopic Ultrasound-Guided Fine Needle Aspiration - methods</topic><topic>Humans</topic><topic>magnetic resonance spectroscopic imaging</topic><topic>Magnetic Resonance Spectroscopy</topic><topic>Male</topic><topic>Middle Aged</topic><topic>prostate cancer</topic><topic>Prostate-Specific Antigen - blood</topic><topic>Prostatic Neoplasms - blood</topic><topic>Prostatic Neoplasms - pathology</topic><topic>Retrospective Studies</topic><topic>transrectal ultrasound-guided biopsy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Javali, Tarun Dilip</creatorcontrib><creatorcontrib>Dwivedi, Durgesh Kumar</creatorcontrib><creatorcontrib>Kumar, Rajeev</creatorcontrib><creatorcontrib>Jagannathan, Naranamangalam Raghunathan</creatorcontrib><creatorcontrib>Thulkar, Sanjay</creatorcontrib><creatorcontrib>Dinda, Amit Kumar</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of urology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Javali, Tarun Dilip</au><au>Dwivedi, Durgesh Kumar</au><au>Kumar, Rajeev</au><au>Jagannathan, Naranamangalam Raghunathan</au><au>Thulkar, Sanjay</au><au>Dinda, Amit Kumar</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Magnetic resonance spectroscopy imaging-directed transrectal ultrasound biopsy increases prostate cancer detection in men with prostate-specific antigen between 4-10 ng/mL and normal digital rectal examination</atitle><jtitle>International journal of urology</jtitle><addtitle>Int J Urol</addtitle><date>2014-03</date><risdate>2014</risdate><volume>21</volume><issue>3</issue><spage>257</spage><epage>262</epage><pages>257-262</pages><issn>0919-8172</issn><eissn>1442-2042</eissn><abstract>Objectives To evaluate the ability of magnetic resonance spectroscopic imaging to improve prostate cancer detection rate. Methods A retrospective analysis was carried out of 278 men with prostate‐specific antigen in the range of 4–10 ng/mL and normal digital rectal examination who underwent transrectal ultrasound‐guided prostate biopsy. Outcomes were compared between men who had a standard biopsy versus those who also underwent a prebiopsy magnetic resonance spectroscopic imaging. Men with an abnormal voxel on magnetic resonance spectroscopic imaging had standard transrectal ultrasound biopsies plus biopsies directed to the abnormal voxels. Results The study group (n = 140) and control group (n = 138) were similar in baseline parameters, such as mean age, prostate size and mean prostate‐specific antigen. The overall cancer detection in the magnetic resonance spectroscopic imaging positive group (24.4%) was more than double that of the control group (10.1%). On comparing the magnetic resonance spectroscopic imaging results with the transrectal ultrasound biopsy findings, magnetic resonance spectroscopic imaging had 95.6% sensitivity, 41.9% specificity, a positive predictive value of 24.4%, a negative predictive value of 98% and an accuracy of 51.4%. Conclusions Magnetic resonance spectroscopic imaging‐directed transrectal ultrasound biopsy increases the cancer detection rate compared with standard transrectal ultrasound biopsy in patients with normal digital rectal examination and elevated prostate‐specific antigen in the range of 4–10 ng/mL.</abstract><cop>Australia</cop><pub>Blackwell Publishing Ltd</pub><pmid>23980749</pmid><doi>10.1111/iju.12258</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0919-8172
ispartof International journal of urology, 2014-03, Vol.21 (3), p.257-262
issn 0919-8172
1442-2042
language eng
recordid cdi_proquest_miscellaneous_1504162485
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects Digital Rectal Examination
Endoscopic Ultrasound-Guided Fine Needle Aspiration - methods
Humans
magnetic resonance spectroscopic imaging
Magnetic Resonance Spectroscopy
Male
Middle Aged
prostate cancer
Prostate-Specific Antigen - blood
Prostatic Neoplasms - blood
Prostatic Neoplasms - pathology
Retrospective Studies
transrectal ultrasound-guided biopsy
title Magnetic resonance spectroscopy imaging-directed transrectal ultrasound biopsy increases prostate cancer detection in men with prostate-specific antigen between 4-10 ng/mL and normal digital rectal examination
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T13%3A38%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Magnetic%20resonance%20spectroscopy%20imaging-directed%20transrectal%20ultrasound%20biopsy%20increases%20prostate%20cancer%20detection%20in%20men%20with%20prostate-specific%20antigen%20between%204-10%E2%80%89ng/mL%20and%20normal%20digital%20rectal%20examination&rft.jtitle=International%20journal%20of%20urology&rft.au=Javali,%20Tarun%20Dilip&rft.date=2014-03&rft.volume=21&rft.issue=3&rft.spage=257&rft.epage=262&rft.pages=257-262&rft.issn=0919-8172&rft.eissn=1442-2042&rft_id=info:doi/10.1111/iju.12258&rft_dat=%3Cproquest_cross%3E1504162485%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1504162485&rft_id=info:pmid/23980749&rfr_iscdi=true